What New FDA Guidance Documents May Mean for Pharma

Back in October, the Food and Drug Administration (FDA) published a series of documents regarding Abbreviated New Drug Applications (ANDAs) for the “genericization” of drugs, with an emphasis placed on simplifying the process by which companies can produce generic versions of complex drugs. Here is your guide.